Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $652,050 - $797,391
18,900 Added 74.7%
44,200 $1.86 Million
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $842,996 - $1.04 Million
25,300 New
25,300 $901,000
Q2 2022

Feb 14, 2023

SELL
$63.06 - $84.75 $318,453 - $427,987
-5,050 Reduced 35.82%
9,050 $648,000
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $318,453 - $427,987
-5,050 Reduced 35.82%
9,050 $649,000
Q1 2022

Feb 14, 2023

BUY
$74.15 - $99.36 $1.05 Million - $1.4 Million
14,100 New
14,100 $1.14 Million
Q1 2022

May 13, 2022

SELL
$74.15 - $99.36 $370,750 - $496,800
-5,000 Reduced 26.18%
14,100 $1.14 Million
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $1.31 Million - $1.56 Million
15,200 Added 389.74%
19,100 $1.96 Million
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $127,050 - $144,465
-1,500 Reduced 27.78%
3,900 $341,000
Q2 2021

Aug 13, 2021

SELL
$76.44 - $89.57 $45,864 - $53,741
-600 Reduced 10.0%
5,400 $483,000
Q1 2021

May 14, 2021

SELL
$67.36 - $80.76 $6.35 Million - $7.62 Million
-94,300 Reduced 94.02%
6,000 $455,000
Q4 2020

Feb 12, 2021

BUY
$53.08 - $69.86 $276,016 - $363,272
5,200 Added 5.47%
100,300 $6.83 Million
Q3 2020

Nov 13, 2020

BUY
$51.29 - $65.09 $4.06 Million - $5.16 Million
79,200 Added 498.11%
95,100 $5.06 Million
Q2 2020

Aug 14, 2020

SELL
$34.32 - $62.43 $24,024 - $43,701
-700 Reduced 4.22%
15,900 $926,000
Q1 2020

May 15, 2020

SELL
$32.64 - $73.63 $114,240 - $257,704
-3,500 Reduced 17.41%
16,600 $654,000
Q4 2019

Feb 18, 2020

SELL
$48.0 - $59.55 $4.41 Million - $5.47 Million
-91,900 Reduced 82.05%
20,100 $1.2 Million
Q3 2019

Nov 14, 2019

SELL
$46.64 - $55.39 $83,952 - $99,702
-1,800 Reduced 1.58%
112,000 $5.96 Million
Q2 2019

Aug 13, 2019

BUY
$40.81 - $52.42 $4.64 Million - $5.97 Million
113,800 New
113,800 $5.81 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.